Aclarion Inc/$ACON
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aclarion Inc
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Ticker
$ACON
Sector
Primary listing
Employees
-
Headquarters
Website
Aclarion Inc Metrics
BasicAdvanced
$5.6M
-
-$12.12
1.34
-
Price and volume
Market cap
$5.6M
Beta
1.34
52-week high
$15.08
52-week low
$6.20
Average daily volume
255K
Financial strength
Current ratio
23.813
Quick ratio
22.83
Interest coverage (TTM)
-88.17%
Profitability
EBITDA (TTM)
-6.121
Gross margin (TTM)
-26.37%
Net profit margin (TTM)
-11,110.66%
Operating margin (TTM)
-10,064.55%
Management effectiveness
Return on assets (TTM)
-44.35%
Return on equity (TTM)
-88.35%
Valuation
Price to revenue (TTM)
89.648
Price to book
0.4
Price to tangible book (TTM)
0.44
Price to free cash flow (TTM)
-0.85
Free cash flow yield (TTM)
-117.69%
Free cash flow per share (TTM)
-11.404
Growth
Revenue change (TTM)
16.68%
3-year revenue growth (CAGR)
13.95%
Aclarion Inc News
AllArticlesVideos
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
MCAP MediaWire3 hours ago
Aclarion to Present at the LD Micro Main Event XIX
Newsfile Corp5 days ago
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
MCAP MediaWire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aclarion Inc stock?
Aclarion Inc (ACON) has a market cap of $5.6M as of October 14, 2025.
What is the P/E ratio for Aclarion Inc stock?
The price to earnings (P/E) ratio for Aclarion Inc (ACON) stock is 0 as of October 14, 2025.
Does Aclarion Inc stock pay dividends?
No, Aclarion Inc (ACON) stock does not pay dividends to its shareholders as of October 14, 2025.
When is the next Aclarion Inc dividend payment date?
Aclarion Inc (ACON) stock does not pay dividends to its shareholders.
What is the beta indicator for Aclarion Inc?
Aclarion Inc (ACON) has a beta rating of 1.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.